| SOXS 1.79 4.07% | NVDA 177.19 -4.16% | ONMD 1.02 44.60% | NFLX 96.24 13.77% | JEM 0.096 3.90% | ENSC 0.6232 57.77% | BYND 0.9456 15.32% | PLUG 1.79 -6.28% | SOFI 17.76 -7.02% | NVD 7.53 8.50% | TZA 6.23 5.06% | NU 14.98 -0.53% | DUST 3.54 -3.50% | BITO 9.06 -2.78% | EOSE 5.695 -15.50% | XLF 51.43 -2.04% | BAC 49.83 -4.72% | AAL 13.07 -6.24% | MARA 8.94 5.80% | VEEA 0.5071 17.33% | SPY 685.99 -0.48% | SOXL 62.77 -3.93% | SLV 84.99 5.64% | XWEL 1.49 9.56% | QQQ 607.29 -0.32% | ONDS 10.08 -3.54% | BHAT 0.0495 -11.13% | PSKY 13.51 20.84% | INTC 45.61 0.33% | F 14.095 -2.19% | AAPL 264.18 -3.21% | XLE 55.92 1.58% | TQQQ 49.52 -1.06% | TSLA 402.51 -1.49% | HYG 80.72 -0.16% | TSDD 9.18 2.91% | TSLL 14.7 -3.10% | BATL 5.52 33.01% | RKT 18.19 2.36% | RXT 1.95 -14.47% | TLT 90.82 0.61% | TSLS 5.64 1.62% | WBD 28.17 -2.19% | PATH 10.73 0.14% | CRWV 79.56 -18.51% | IBIT 37.19 -2.80% | LQD 111.68 -0.04% | SOUN 8.6015 -4.21% | PLTR 137.19 0.92% | CPNG 19.08 1.98%

CNO Financial Group, Inc. (NYSE:CNO) Insider Sale and Financial Overview

CNO Financial Group, Inc. (NYSE:CNO) is a prominent player in the insurance industry, providing health and life insurance products. The company operates through its subsidiaries, including Bankers Life and Casualty Company, Colonial Penn Life Insurance Company, and Washington National Insurance Company. CNO competes with other insurance giants like MetLife and Prudential Financial. On February 12, 2026, Matthew J. Zimpfer, CNO's General Counsel, sold 30,970 shares of the company's common stock at approximately $42.93 each. This transaction leaves Zimpfer with 307,937 shares.

Despite this sale, CNO continues to reward its shareholders with a quarterly cash dividend of $0.17 per share, payable on March 24, 2026, to those recorded by March 10, 2026. CNO's financial metrics provide insight into its market position. The company's price-to-earnings (P/E) ratio is around 32.45, indicating investor confidence in its earnings potential. The price-to-sales ratio of 0.92 suggests that the market values CNO's sales at less than one times its revenue, while the enterprise value to sales ratio of 1.60 reflects its total valuation compared to sales. The enterprise value to operating cash flow ratio stands at approximately 10.71, showing how CNO's valuation compares to its cash flow from operations. The earnings yield is about 3.08%, offering a glimpse into the return on investment for shareholders.

Additionally, the debt-to-equity ratio of 1.54 highlights CNO's reliance on debt financing relative to its equity. CNO's annual meeting of shareholders is scheduled for May 12, 2026, and will be held virtually. Shareholders recorded by March 16, 2026, can participate, vote, and submit questions. Notably, Nina Henderson, a long-serving Board member, will retire at the end of her term, concluding with the annual meeting. Henderson has been instrumental as Chair of the Human Resources and Compensation Committee.

Published on: February 13, 2026